not tagged
not tagged
[]
krijbolder et al. treat earlier dbrct. mtx vs pbo for pre-ra. treat 1 year, stop, and follow 1 year. no difference in ra development. delay in acpa+ or high risk. sustained benefit in mtx group on pain, ems, function, mri. #acr22 abstr#1603 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC